Transcutaneous Auricular Vagus Nerve Stimulation as Adjuvant Treatment for Sepsis Patients
RecruitingNCT07051694Phase: NAStarted 2025-02-27
Summary
The goals of this randomized clinical trial are to investigate the effects of transcutaneous auricular vagus nerve stimulation (taVNS) combined with standard intensive care on systemic organ function
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
80 Years
Locations
The First Affiliated Hospital of Army Medical UniversityChongqing, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07051694